Diagnostic Microbiology & Infectious Disease
Volume 62, Issue 3 , Pages 263-271, November 2008

Development of multiplexed real-time quantitative polymerase chain reaction assay for detecting human adenoviruses☆☆

  • Meei-Li Huang

      Affiliations

    • Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA
    • Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
  • ,
  • Long Nguy

      Affiliations

    • Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA
    • Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
  • ,
  • James Ferrenberg

      Affiliations

    • Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
  • ,
  • Michael Boeckh

      Affiliations

    • Department of Medicine, University of Washington, Seattle, WA 98195, USA
    • Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
  • ,
  • Anne Cent

      Affiliations

    • Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA
  • ,
  • Lawrence Corey

      Affiliations

    • Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA
    • Department of Medicine, University of Washington, Seattle, WA 98195, USA
    • Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    • Corresponding Author InformationCorresponding author. Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. Tel.: +1-206-667-6702; fax: +1-206-667-7711.

Received 3 April 2008; accepted 25 June 2008. published online 19 August 2008.

Abstract 

Adenoviruses (AdVs) have been associated with a wide variety of human disease and are increasingly recognized as viral pathogens that can cause significant morbidity and mortality in immunocompromised patients. Early detection of AdV DNA in plasma and sterile fluids has been shown to be useful for identifying patients at risk for invasive AdV disease. Because of the large number of existing Adv types, few real-time quantitative AdV polymerase chain reaction (PCR) assays published effectively cover all AdV types. We designed a series of AdV PCR primers and probes and empirically multiplexed them into 2 separate real-time PCR assays to quantitatively detect all 49 serotypes of human AdV (types 1–49) available from American Type Culture Collection. We then subsequently multiplexed all the primers and probes into 1 reaction. The sensitivity of these assays was determined to be less than 10 copies per reaction (500 copies/mL plasma). In a retrospective evaluation, we detected all 84 clinical AdV isolates isolated in cell culture from patients undergoing hematopoietic stem cell transplantation between 1981 and 1987. Prospective analysis of 46 consecutive clinical samples submitted for AdV testing showed greater sensitivity and equal specificity of the AdV PCR than viral culture. This real-time PCR assay allows rapid, sensitive, and specific quantification of all currently defined AdVs into either 2 or 1 multiplex assay for clinical samples.

Keywords: Adenovirus, Multiplex, Real-time, PCR

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors do not have any commercial or other association that might pose a conflict of interest.

☆☆ The work was supported by grants AI-30731, CA-18029, HL-081595, and AI-46747.

PII: S0732-8893(08)00297-6

doi:10.1016/j.diagmicrobio.2008.06.009

Diagnostic Microbiology & Infectious Disease
Volume 62, Issue 3 , Pages 263-271, November 2008